Downregulation of neuronal cyclooxygenase-2 expression in end stage Alzheimer's disease

Neurobiology of Aging

Volumn 22, Issue 6, 2001, Pages 823-836

  Yermakova, Anna V ^a   Kerry O'Banion M ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Alzheimer's disease; Astrocytes; CNS; Hippocampus; Human; Nonsteroidal anti inflammatory drugs; Prostaglandin endoperoxide synthase

Indexed keywords

CYCLOOXYGENASE 2;

ALZHEIMER DISEASE; ARTICLE; ASTROCYTE; CELL DENSITY; CONTROLLED STUDY; DEMENTIA; DISEASE ASSOCIATION; DOWN REGULATION; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; INFLAMMATION; NERVE CELL; PAIRED HELICAL FILAMENT; PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AGED; AGING; ALZHEIMER DISEASE; ANTIBODY SPECIFICITY; ASTROCYTES; AUTOPSY; BLOTTING, WESTERN; BRAIN; CEREBRAL CORTEX; CYCLOOXYGENASE 2; DOWN-REGULATION; HIPPOCAMPUS; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; MEMBRANE PROTEINS; MUSCLE, SMOOTH, VASCULAR; NEUROGLIA; NEURONS; POSTMORTEM CHANGES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SEX CHARACTERISTICS; TAU PROTEINS;

EID: 0035693794     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(01)00303-7     Document Type: Article

References (76)

1. Cyclooxygenase-2 induction in cerebral cortex: An intracellular response to synaptic excitation
2. Hippocampal formation
3. Cyclooxygenase-2 is widely expressed in atherosclerotic lesions affecting native, and transplanted human coronary arteries, and colocalizes with inducible nitric oxide synthase, and nitrotyrosine particularly in macrophages
4. Expression and regulation of cyclooxygenase-2 in rat microglia
5. Sources of reactive oxygen species production in excitotoxin-stimulated cerebellar granule cells
6. Neuropathological stageing of Alzheimer-related changes
7. Cyclooxygenase systems in the mammalian brain
8. Characterization of inducible cyclooxygenase in rat brain
9. The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer's disease
10. Lipopolysaccharide injected into the cerebral ventricle evokes fever through induction of cyclooxygenase-2 in brain endothelial cells
11. Involvement of cyclooxygenase-2 in LPS-induced fever and regulation of its mRNA by LPS in the rat brain
12. A selective inhibitor of cyclooxygenase-2 reverses endotoxin-induced pyretic responses in non-human primates
13. Prostaglandin G/H synthase-2 (cyclooxygenase-2) mRNA expression is decreased in Alzheimer's disease
14. Cyclo-oxygenase-2 messenger RNA induction in focal cerebral ischemia
15. Inflammatory mechanisms in Alzheimer's disease: Inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARγ agonists
16. Synaptic dysfunction in Alzheimer's disease: Clinical assessment using quantitative EEG
17. Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
18. Cyclooxygenase in biology and disease
19. 2 induces interleukin-6 (IL-6) synthesis in human astrocytoma cells
20. Molecular pathology of cyclooxygenase-2 in neoplasia
21. Inflammatory pathways: Implications in Alzheimer's disease
22. Glial-neuronal interactions in Alzheimer's disease: The potential role of a 'cytokine cycle' in disease progression
23. Cyanide-induced generation of oxidative species: Involvement of nitric oxide synthase and cyclooxygenase-2
24. Synaptic loss in Alzheimer's disease and other dementias
25. Cyclooxygenase-2 is associated with the macula densa of rat kidney, and increases with salt restriction
26. Expression of COX-2 by normal and reactive astrocytes in the adult rat central nervous system
27. Regional distribution of cyclooxygenase-2 in the hippocampal formation in Alzheimer's disease
28. Neuronal cyclooxygenase-2 expression in the hippocampal formation as a function of the clinical progression of Alzheimer's disease
29. Cyclooxygenase-2 immunoreactivity in the human brain following cerebral ischemia
30. Negative feedback between prostaglandin and α- and β-chemokine synthesis in human microglial cells and astroctyes
31. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
32. The role of the electroencephalogram in the diagnosis of dementia of the Alzheimer type: An attempt at technology assessment
33. Cyclooxygenase-1 behaves as a delayed response gene in PC12 cells differentiated by nerve growth factor
34. Synaptic loss reflected by secretoneurin-like immunoreactivity in the human hippocampus in Alzheimer's disease
35. Increased expression of cyclooxygenases and peroxisome proliferator-activated receptor-gamma in Alzheimer's disease brains
36. 2 stimulates amyloid precussor protein gene expression: Inhibition by immunosuppressants
37. Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs
38. The febrile response to lipopolysaccharide is blocked in cyclooxygenase-2-/-, but not in cyclooxygenase-1-/- mice
39. Inflammation, A beta deposition, and neurofibrillary tangle formation as correlates of Alzheimer's disease neurodegeneration
40. Cyclooxygenase 2 RNA message abundance, stability, and hypervariability in sporadic Alzheimer neocortex
41. Sustained induction of prostaglandin endoperoxide synthase-2 by seizures in hippocampus
42. Expression of cyclooxygenase-2 in astrocytes of human brain after global ischemia
43. Brain endothelial cells express cyclooxygenase-2 during lipopolysaccharide-induced fever: Light and electron microscopic immunocytochemical studies
44. Inflammatory responses to amyloidosis in a transgenic mouse model of Alzheimer's disease
45. Cyclo-oxygenase-2 inhibitors: Rationale, and therapeutic potential for Alzheimer's disease
46. Inflammation of the brain in Alzheimer's disease: Implications for therapy
47. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: A review of 17 epidemiological studies
48. Constitutive expression of cyclooxygenase-2 in rat vas deferens
49. Penetration of cisplatin into mouse brain by lipopolysaccharide
50. 2, cyclic AMP, and non-steroidal anti-inflammatory drugs
51. The Clinical Dementia Rating (CDR): Current version and scoring rules
52. Clinical demetia rating: A reliable and valid diagnostic and staging measure for dementia of the Alzheimer type
53. Cyclooxygenase-2 inhibition prevents delayed death of CA1 hippocampal neurons following global ischemia
54. Effects of protein kinase C activation on prostaglandin production and cyclooxygenase mRNA levels in ovine astroglia
55. Cyclooxygenase-2 gene expression in neurons contributes to ischemic brain damage
56. The potential of cyclooxygenase inhibitors in treatment and prevention of Alzheimer's disease
57. Cyclooxygenase-2: Molecular biology, pharmacology, and neurobiology
58. IL-1β induces prostaglandin G/H synthase-2 (cyclooxygenase-2) in primary murine astrocyte cultures
59. Localization and distribution of cyclooxygenase-2 in brain tissue by immunocytochemistry
60. Induction of cyclooxygenase 2 in brains of patients with Down's syndrome and dementia of the Alzheimer's type: Specific localization in affected neurones and axons
61. Two opposing effects of non-steroidal anti-inflammatory drugs on the expression of the inducible cyclooxygenase
62. Soluble beta-amyloid peptides mediate vasoactivity via activation of a pro-inflammatory pathway
63. Cyclooxygenase and inflammation in Alzheimer's disease: Experimental approaches and clinical interventions
64. Inflammatory mediators in Alzheimer's disease
65. 2, and cyclooxygenase-2 in the hippocampus after kainate lesions
66. Augmented expression of cyclooxygenase-2 in human atherosclerotic lesions
67. Risk of Alzheimer's disease and duration of NSAID use
68. Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment
69. Immunofluorescent localization of constitutive and inducible prostaglandin H synthase in ovine astroglia
70. 2 in the hypoxic-ischemic brain: Role in neuronal death or survival?
71. The role of cyclooxygenases in inflammation, cancer, and development
72. Expression of a mitogen-inducible cyclooxygenase in brain neurons: Regulation by synaptic activity and glucocorticoids
73. Distribution of cyclooxygenase-1 and cyclooxygenase-2 mRNAs and proteins in human brain and peripheral organs
74. Cyclooxygenase-1 in human Alzheimer's, and control brain: Quantitative analysis of expression by microglia, and CA3 hippocampal neurons
75. The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β
76. Brain electrical activity (quantitative EEG and bit-mapping neurocognitive CNV components), psychometrics and clinical findings in presenile subjects with initial mild cognitive decline or probable Alzheimer-type dementia